Chapter 51: Immunizations – Vaccines & Clinical Guidelines

The text delineates the two primary methods of immunoprophylaxis: active immunization, where attenuated or killed vaccines stimulate the body’s long-term immune defenses, and passive immunization, which involves administering preformed antibodies for immediate, short-term protection, often necessary in high-risk exposures. Recommendations, updated yearly by the Centers for Disease Control and Prevention (CDC) and the Advisory Committee on Immunization Practices (ACIP), cover detailed schedules for infants, children, adolescents, and adults, emphasizing the need for flexible scheduling and universal screening at all health care visits. Special consideration is dedicated to vulnerable groups, including preterm infants, transplant recipients, and individuals with immunosuppression, for whom live virus vaccines are often contraindicated due to safety concerns and reduced efficacy; guidelines are specified for patients receiving corticosteroid therapy based on dose and duration. The chapter reviews numerous essential vaccines, including the necessary series for Hepatitis B starting at birth, combination vaccines like MMR and DTaP, adolescent protection against Meningococcus (MenACWY and MenB) and HPV, and adult requirements such as annual Influenza shots and multi-dose series for Pneumococcal infection (PCV-13 and PPSV-23, especially for older adults, smokers, and those with chronic conditions). Finally, the importance of robust practice standards is highlighted, requiring strict adherence to true contraindications (like severe allergy or moderate/severe acute illness), proper vaccine management and storage, and mandatory reporting of unexpected events through the Vaccine Adverse Events Reporting System (VAERS).